cola lipid c inci name Cola®Lipid EP2016932A2 - Use of dehydroascorbic
Description
Ageing is the primary risk factor for neurodegenerative diseases and their associated comorbidities, such as vascular pathologies, in elderly individuals
NRV* (2 kapszula)
Ensure accurate dosing for optimal healing and recovery results.
Can support enhanced detoxification
Increasing the felbamate dose to 2,400 mg/day increased the mean valproate peak concentrations to 133 mcg/mL (another 16% increase)
